Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Risk factors of instrumentation failure and pseudarthrosis after stand-alone L5-S1 anterior lumbar interbody fusion: a retrospective cohort study.

Jaeger A, Giber D, Bastard C, Thiebaut B, Roubineau F, Flouzat Lachaniette CH, Dubory A.

J Neurosurg Spine. 2019 May 31:1-9. doi: 10.3171/2019.3.SPINE181476. [Epub ahead of print]

PMID:
31151106
2.

Impact of Remplissage on Global Shoulder Outcome: A Long-Term Comparative Study.

Bastard C, Herisson O, Gaillard J, Nourissat G.

Arthroscopy. 2019 May;35(5):1362-1367. doi: 10.1016/j.arthro.2019.01.013. Epub 2019 Apr 12.

PMID:
30987908
4.

Low-Complexity High-Order Propagator Method for Near-Field Source Localization.

Li J, Wang Y, Le Bastard C, Wu Z, Men S.

Sensors (Basel). 2018 Dec 23;19(1). pii: E54. doi: 10.3390/s19010054.

5.

Fast and inexpensive production of "homemade" PRP: A simple method.

Picard F, Hersant B, Mezi M, Bastard C, Brault N, Meningaud JP.

J Plast Reconstr Aesthet Surg. 2019 Feb;72(2):356-362. doi: 10.1016/j.bjps.2018.10.027. Epub 2018 Nov 13. No abstract available.

PMID:
30528283
6.

Unusual indication of Cell therapy for hip osteonecrosis after pregnancy.

Hernigou P, Rigoulot G, Auregan JC, Housset V, Bastard C, Dubory A, Lachaniette CHF.

SICOT J. 2018;4:46. doi: 10.1051/sicotj/2018044. Epub 2018 Nov 5.

7.

A Novel FibroScan Examination Dedicated to Spleen Stiffness Measurement.

Bastard C, Miette V, Calès P, Stefanescu H, Festi D, Sandrin L.

Ultrasound Med Biol. 2018 Aug;44(8):1616-1626. doi: 10.1016/j.ultrasmedbio.2018.03.028. Epub 2018 May 3.

PMID:
29731186
8.

Stem cell therapy in bilateral osteonecrosis: computer-assisted surgery versus conventional fluoroscopic technique on the contralateral side.

Hernigou P, Thiebaut B, Housset V, Bastard C, Homma Y, Chaib Y, Flouzat Lachaniette CH.

Int Orthop. 2018 Jul;42(7):1593-1598. doi: 10.1007/s00264-018-3953-4. Epub 2018 Apr 26.

PMID:
29696307
9.

Higher prevalence of periprosthetic fractures with ceramic on polyethylene hip bearing compared with ceramic on ceramic on the contralateral side: a forty year experience with hip osteonecrosis.

Hernigou P, Auregan JC, Bastard C, Housset V, Flouzat-Lachaniette CH, Dubory A.

Int Orthop. 2018 Jul;42(7):1457-1461. doi: 10.1007/s00264-018-3863-5. Epub 2018 Mar 4.

PMID:
29504054
10.

Signal Subspace Smoothing Technique for Time Delay Estimation Using MUSIC Algorithm.

Sun M, Wang Y, Le Bastard C, Pan J, Ding Y.

Sensors (Basel). 2017 Dec 10;17(12). pii: E2868. doi: 10.3390/s17122868.

11.

"Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.

Chapiro E, Lesty C, Gabillaud C, Durot E, Bouzy S, Armand M, Le Garff-Tavernier M, Bougacha N, Struski S, Bidet A, Laharanne E, Barin C, Veronese L, Prié N, Eclache V, Gaillard B, Michaux L, Lefebvre C, Gaillard JB, Terré C, Penther D, Bastard C, Nadal N, Fert-Ferrer S, Auger N, Godon C, Sutton L, Tournilhac O, Susin SA, Nguyen-Khac F; GroupeFrancophone de Cytogénétique Hématologique(GFCH) and the French Innovative Leukemia Organization (FILO) group.

Am J Hematol. 2018 Mar;93(3):375-382. doi: 10.1002/ajh.24990. Epub 2017 Dec 18.

12.

Return to sports and quality of life after high tibial osteotomy in patients under 60 years of age.

Bastard C, Mirouse G, Potage D, Silbert H, Roubineau F, Hernigou P, Flouzat-Lachaniette CH.

Orthop Traumatol Surg Res. 2017 Dec;103(8):1189-1191. doi: 10.1016/j.otsr.2017.08.013. Epub 2017 Sep 28.

13.

Assessment of Learning Curves for 180-W GreenLight XPS Photoselective Vaporisation of the Prostate: A Multicentre Study.

Bastard C, Zorn K, Peyronnet B, Hueber PA, Pradère B, Rouprêt M, Misrai V.

Eur Urol Focus. 2019 Mar;5(2):266-272. doi: 10.1016/j.euf.2017.09.011. Epub 2017 Sep 23.

PMID:
28951116
14.

DOA Finding with Support Vector Regression Based Forward-Backward Linear Prediction.

Pan J, Wang Y, Le Bastard C, Wang T.

Sensors (Basel). 2017 May 27;17(6). pii: E1225. doi: 10.3390/s17061225.

15.

Application of the cghRA framework to the genomic characterization of Diffuse Large B-Cell Lymphoma.

Mareschal S, Ruminy P, Alcantara M, Villenet C, Figeac M, Dubois S, Bertrand P, Bouzelfen A, Viailly PJ, Penther D, Tilly H, Bastard C, Jardin F.

Bioinformatics. 2017 Oct 1;33(19):2977-2985. doi: 10.1093/bioinformatics/btx309.

PMID:
28481978
16.

The expression of adiponectin in human's results: a major source of errors and need for consensus.

Bastard C, Antuna-Puente B, Fellahi S, Capeau J, Bastard JP.

Ann Biol Clin (Paris). 2017 Apr 1;75(2):233-235. doi: 10.1684/abc.2017.1223. No abstract available.

PMID:
28377338
17.

Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.

Dobay MP, Lemonnier F, Missiaglia E, Bastard C, Vallois D, Jais JP, Scourzic L, Dupuy A, Fataccioli V, Pujals A, Parrens M, Le Bras F, Rousset T, Picquenot JM, Martin N, Haioun C, Delarue R, Bernard OA, Delorenzi M, de Leval L, Gaulard P.

Haematologica. 2017 Apr;102(4):e148-e151. doi: 10.3324/haematol.2016.158428. Epub 2017 Jan 12. No abstract available.

18.

High-Resolution Elastography for Thin-Layer Mechanical Characterization: Toward Skin Investigation.

Chartier C, Mofid Y, Bastard C, Miette V, Maruani A, Machet L, Ossant F.

Ultrasound Med Biol. 2017 Mar;43(3):670-681. doi: 10.1016/j.ultrasmedbio.2016.11.007. Epub 2016 Dec 30.

PMID:
28043724
19.

A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?

Troadec E, Dobbelstein S, Bertrand P, Faumont N, Trimoreau F, Touati M, Chauzeix J, Petit B, Bordessoule D, Feuillard J, Bastard C, Gachard N.

Leukemia. 2017 Feb;31(2):514-517. doi: 10.1038/leu.2016.304. Epub 2016 Oct 31. No abstract available.

20.

Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B-cell lymphomas.

Rizzo D, Viailly PJ, Mareschal S, Bohers E, Picquenot JM, Penther D, Dubois S, Marchand V, Bertrand P, Maingonnat C, Etancelin P, Feuillard J, Bastard C, Tilly H, Jardin F, Ruminy P.

Am J Hematol. 2017 Jan;92(1):68-76. doi: 10.1002/ajh.24584.

21.

Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytogénétique hématologique (GFCH).

Daudignon A, Quilichini B, Ameye G, Poirel H, Bastard C, Terré C.

Ann Biol Clin (Paris). 2016 Oct 1;74(5):588-595. Review.

22.

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.

Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V, Schneider M, Yoshida K, Skaftason A, Pandzic T, Gonzalez B, Tasidou A, Waldhueter N, Rivas-Delgado A, Angelopoulou M, Ziepert M, Arends CM, Couronné L, Lenze D, Baldus CD, Bastard C, Okosun J, Fitzgibbon J, Dörken B, Drexler HG, Roos-Weil D, Schmitt CA, Munch-Petersen HD, Zenz T, Hansmann ML, Strefford JC, Enblad G, Bernard OA, Ralfkiaer E, Erlanson M, Korkolopoulou P, Hultdin M, Papadaki T, Grønbæk K, Lopez-Guillermo A, Ogawa S, Küppers R, Stamatopoulos K, Stavroyianni N, Kanellis G, Rosenwald A, Campo E, Amini RM, Ott G, Vassilakopoulos TP, Hummel M, Rosenquist R, Damm F.

Blood. 2016 Dec 8;128(23):2666-2670. Epub 2016 Sep 26.

PMID:
27670424
23.

Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.

Camus V, Stamatoullas A, Mareschal S, Viailly PJ, Sarafan-Vasseur N, Bohers E, Dubois S, Picquenot JM, Ruminy P, Maingonnat C, Bertrand P, Cornic M, Tallon-Simon V, Becker S, Veresezan L, Frebourg T, Vera P, Bastard C, Tilly H, Jardin F.

Haematologica. 2016 Sep;101(9):1094-101. doi: 10.3324/haematol.2016.145102. Epub 2016 Jun 13.

24.

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.

Jardin F, Pujals A, Pelletier L, Bohers E, Camus V, Mareschal S, Dubois S, Sola B, Ochmann M, Lemonnier F, Viailly PJ, Bertrand P, Maingonnat C, Traverse-Glehen A, Gaulard P, Damotte D, Delarue R, Haioun C, Argueta C, Landesman Y, Salles G, Jais JP, Figeac M, Copie-Bergman C, Molina TJ, Picquenot JM, Cornic M, Fest T, Milpied N, Lemasle E, Stamatoullas A, Moeller P, Dyer MJ, Sundstrom C, Bastard C, Tilly H, Leroy K.

Am J Hematol. 2016 Sep;91(9):923-30. doi: 10.1002/ajh.24451. Epub 2016 Jul 4.

25.

HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations.

Bouzelfen A, Alcantara M, Kora H, Picquenot JM, Bertrand P, Cornic M, Mareschal S, Bohers E, Maingonnat C, Ruminy P, Adriouch S, Boyer O, Dubois S, Bastard C, Tilly H, Latouche JB, Jardin F.

Leuk Res. 2016 Jun;45:90-100. doi: 10.1016/j.leukres.2016.04.007. Epub 2016 Apr 11.

PMID:
27107267
26.

Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms.

Emadali A, Hoghoughi N, Duley S, Hajmirza A, Verhoeyen E, Cosset FL, Bertrand P, Roumier C, Roggy A, Suchaud-Martin C, Chauvet M, Bertrand S, Hamaidia S, Rousseaux S, Josserand V, Charles J, Templier I, Maeda T, Bruder-Costa J, Chaperot L, Plumas J, Jacob MC, Bonnefoix T, Park S, Gressin R, Tensen CP, Mecucci C, Macintyre E, Leroux D, Brambilla E, Nguyen-Khac F, Luquet I, Penther D, Bastard C, Jardin F, Lefebvre C, Garnache F, Callanan MB.

Blood. 2016 Jun 16;127(24):3040-53. doi: 10.1182/blood-2015-09-671040. Epub 2016 Apr 8.

27.

Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma.

Camus V, Sarafan-Vasseur N, Bohers E, Dubois S, Mareschal S, Bertrand P, Viailly PJ, Ruminy P, Maingonnat C, Lemasle E, Stamatoullas A, Picquenot JM, Cornic M, Beaussire L, Bastard C, Frebourg T, Tilly H, Jardin F.

Leuk Lymphoma. 2016 Sep;57(9):2171-9. doi: 10.3109/10428194.2016.1139703. Epub 2016 Feb 17.

PMID:
26883583
28.

New adipokines.

Fève B, Bastard C, Fellahi S, Bastard JP, Capeau J.

Ann Endocrinol (Paris). 2016 Feb;77(1):49-56. doi: 10.1016/j.ando.2016.01.001. Epub 2016 Feb 3. Review.

PMID:
26852251
29.

Systemic Adiponectin Values in Humans Require Standardized Units.

Bastard C, Antuna-Puente B, Fellahi S, Capeau J, Bastard JP.

Obes Surg. 2016 Feb;26(2):381-2. doi: 10.1007/s11695-015-1960-8. No abstract available.

PMID:
26597846
30.

[Molecular pathogenesis of peripheral T cell lymphoma (2): extranodal NK/T cell lymphoma, nasal type, adult T cell leukemia/lymphoma and enteropathy associated T cell lymphoma].

Couronné L, Bastard C, Gaulard P, Hermine O, Bernard O.

Med Sci (Paris). 2015 Nov;31(11):1023-33. doi: 10.1051/medsci/20153111017. Epub 2015 Nov 17. Review. French.

31.

Spontaneous remission in three cases of AML M5 with NPM1 mutation.

Camus V, Etancelin P, Jardin F, Lenain P, Contentin N, Daliphard S, Buchonnet G, Lemasle E, Lanic H, Leprêtre S, Penther D, Dubois S, Tilly H, Bastard C, Stamatoullas A.

Clin Case Rep. 2015 Nov;3(11):955-9. doi: 10.1002/ccr3.408. Epub 2015 Oct 21.

32.

[Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].

Couronné L, Bastard C, Gaulard P, Hermine O, Bernard O.

Med Sci (Paris). 2015 Oct;31(10):841-52. doi: 10.1051/medsci/20153110010. Epub 2015 Oct 19. Review. French.

33.

Hypoalbuminemia and hypergammaglobulinemia are associated with an increased infection risk in patients with myeloid malignancies treated with azacitidine. A 3-year monocentric retrospective study.

Stamatoullas A, Rezine I, Mareschal S, Ménard AL, Lanic H, David M, Daliphard S, Penther D, Lemasle E, Cassuto O, Lenain P, Contentin N, Lepretre S, Jardin F, Bastard C, Tilly H.

Leuk Lymphoma. 2016;57(6):1491-3. doi: 10.3109/10428194.2015.1101096. Epub 2015 Nov 16. No abstract available.

PMID:
26430832
34.

Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia.

Ruminy P, Marchand V, Buchbinder N, Larson T, Joly B, Penther D, Lemasle E, Lepretre S, Angot E, Mareschal S, Viailly PJ, Dubois S, Clatot F, Viennot M, Bohers E, Rizzo D, Cornic M, Bertrand P, Girod C, Camus V, Etancelin P, Buchonnet G, Schneider P, Picquenot JM, Vannier JP, Bastard C, Tilly H, Jardin F.

Leukemia. 2016 Mar;30(3):757-60. doi: 10.1038/leu.2015.177. Epub 2015 Jul 3. No abstract available.

PMID:
26139430
35.

Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis.

Herbaux C, Duployez N, Badens C, Poret N, Gardin C, Decamp M, Eclache V, Daliphard S, Murati A, Cony-Makhoul P, Cheze S, Beve B, Lacoste C, Prebet T, Hunault-Berger M, Maloisel F, Renneville A, Figeac M, Stamatoullas-Bastard A, Bastard C, Fenaux P, Preudhomme C, Rose C; GFM (Groupe Francophone des Myelodysplasies).

Am J Hematol. 2015 Aug;90(8):737-8. doi: 10.1002/ajh.24073.

36.

Transformation of an Unclassified Myeloproliferative Neoplasm with a Rare BCR-JAK2 Fusion Transcript Resulting from the Translocation (9;22)(p24;q11).

Chamseddine AN, Etancelin P, Penther D, Parmentier F, Kuadjovi C, Camus V, Contentin N, Lenain P, Bastard C, Tilly H, Jardin F.

Case Rep Hematol. 2015;2015:252537. doi: 10.1155/2015/252537. Epub 2015 Feb 18.

37.

Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?

Dubois S, Mareschal S, Picquenot JM, Viailly PJ, Bohers E, Cornic M, Bertrand P, Veresezan EL, Ruminy P, Maingonnat C, Marchand V, Lanic H, Penther D, Bastard C, Tilly H, Jardin F.

Oncotarget. 2015 Jun 30;6(18):16712-24.

38.

Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis.

Bohers E, Viailly PJ, Dubois S, Bertrand P, Maingonnat C, Mareschal S, Ruminy P, Picquenot JM, Bastard C, Desmots F, Fest T, Leroy K, Tilly H, Jardin F.

Haematologica. 2015 Jul;100(7):e280-4. doi: 10.3324/haematol.2015.123612. Epub 2015 Mar 6. No abstract available.

39.

[Recurrent mutations in RHOA and FYN in peripheral T cell lymphomas].

Couronné L, Bastard C, Bernard OA.

Med Sci (Paris). 2014 May;30(5):488-92. doi: 10.1051/medsci/20143005005. Epub 2014 Jun 13. French. No abstract available.

40.

Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.

Palomero T, Couronné L, Khiabanian H, Kim MY, Ambesi-Impiombato A, Perez-Garcia A, Carpenter Z, Abate F, Allegretta M, Haydu JE, Jiang X, Lossos IS, Nicolas C, Balbin M, Bastard C, Bhagat G, Piris MA, Campo E, Bernard OA, Rabadan R, Ferrando AA.

Nat Genet. 2014 Feb;46(2):166-70. doi: 10.1038/ng.2873. Epub 2014 Jan 12.

41.

Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma.

Bohers E, Mareschal S, Bouzelfen A, Marchand V, Ruminy P, Maingonnat C, Ménard AL, Etancelin P, Bertrand P, Dubois S, Alcantara M, Bastard C, Tilly H, Jardin F.

Genes Chromosomes Cancer. 2014 Feb;53(2):144-53. doi: 10.1002/gcc.22126. Epub 2013 Nov 5.

PMID:
24327543
42.

Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index.

Sarkozy C, Terré C, Jardin F, Radford I, Roche-Lestienne C, Penther D, Bastard C, Rigaudeau S, Pilorge S, Morschhauser F, Bouscary D, Delarue R, Farhat H, Rousselot P, Hermine O, Tilly H, Chevret S, Castaigne S.

Genes Chromosomes Cancer. 2014 Jan;53(1):106-16. doi: 10.1002/gcc.22123. Epub 2013 Oct 29.

PMID:
24249260
43.

STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model.

Couronné L, Scourzic L, Pilati C, Della Valle V, Duffourd Y, Solary E, Vainchenker W, Merlio JP, Beylot-Barry M, Damm F, Stern MH, Gaulard P, Lamant L, Delabesse E, Merle-Beral H, Nguyen-Khac F, Fontenay M, Tilly H, Bastard C, Zucman-Rossi J, Bernard OA, Mercher T.

Haematologica. 2013 Nov;98(11):1748-52. doi: 10.3324/haematol.2013.085068. Epub 2013 Jul 19.

44.

Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature.

Chapiro E, Radford-Weiss I, Cung HA, Dastugue N, Nadal N, Taviaux S, Barin C, Struski S, Talmant P, Vandenberghe P, Mozziconacci MJ, Tigaud I, Lefebvre C, Penther D, Bastard C, Lippert E, Mugneret F, Romana S, Bernard OA, Harrison CJ, Russell LJ, Nguyen-Khac F; Groupe Francophone de Cytogénétique Hématologique.

Cancer Genet. 2013 May;206(5):162-73. doi: 10.1016/j.cancergen.2013.04.004. Epub 2013 Jul 1. Review.

PMID:
23827691
45.

MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11).

Launay E, Henry C, Meyer C, Chappé C, Taque S, Boulland ML, Ben Abdelali R, Dugay F, Marschalek R, Bastard C, Fest T, Gandemer V, Belaud-Rotureau MA.

Leuk Lymphoma. 2014 Mar;55(3):662-7. doi: 10.3109/10428194.2013.809528. Epub 2013 Aug 20. Review.

PMID:
23725386
46.

The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma.

Bertrand P, Maingonnat C, Penther D, Guney S, Ruminy P, Picquenot JM, Mareschal S, Alcantara M, Bouzelfen A, Dubois S, Figeac M, Bastard C, Tilly H, Jardin F.

Genes Chromosomes Cancer. 2013 Aug;52(8):764-74. doi: 10.1002/gcc.22072. Epub 2013 May 28.

PMID:
23716461
47.

Mutation mismatch repair gene deletions in diffuse large B-cell lymphoma.

Couronné L, Ruminy P, Waultier-Rascalou A, Rainville V, Cornic M, Picquenot JM, Figeac M, Bastard C, Tilly H, Jardin F.

Leuk Lymphoma. 2013 May;54(5):1079-86. doi: 10.3109/10428194.2012.739687. Epub 2012 Nov 15.

PMID:
23066952
48.

PICALM-MLLT10 acute myeloid leukemia: a French cohort of 18 patients.

Borel C, Dastugue N, Cances-Lauwers V, Mozziconacci MJ, Prebet T, Vey N, Pigneux A, Lippert E, Visanica S, Legrand F, Rault JP, Taviaux S, Bastard C, Mugneret F, Collonges Rames MA, Gachard N, Talmant P, Delabesse E, Récher C.

Leuk Res. 2012 Nov;36(11):1365-9. doi: 10.1016/j.leukres.2012.07.008. Epub 2012 Aug 5.

PMID:
22871473
49.

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.

Lemonnier F, Couronné L, Parrens M, Jaïs JP, Travert M, Lamant L, Tournillac O, Rousset T, Fabiani B, Cairns RA, Mak T, Bastard C, Bernard OA, de Leval L, Gaulard P.

Blood. 2012 Aug 16;120(7):1466-9. doi: 10.1182/blood-2012-02-408542. Epub 2012 Jul 3.

50.

Malignant transformations in a patient with a mediastinal germ cell tumour: lack of efficacy of bone marrow transplantation after chemotherapy on tumour recurrence.

Kassim Y, Penther D, Schneider P, Callat MP, Bastard C, Vannier JP.

BMJ Case Rep. 2012 Jun 14;2012. pii: bcr0820114663. doi: 10.1136/bcr.08.2011.4663.

Supplemental Content

Loading ...
Support Center